Compare Macy's Inc (M) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macy's Inc vs Medpace Holdings Inc — how do they compare? Macy's Inc trades at $24.53 (market cap $6.45B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 2.6× Macy's Inc's market cap, and Macy's Inc pays a 3.12% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| M | MEDP | |
|---|---|---|
Market Cap | $6.45B | $16.90B |
Sector | Consumer Cyclical | Technology |
52-Week High | $26.21 | $620.59 |
52-Week Low | $12.73 | $393.42 |
Enterprise Value | $10.26B | $16.52B |
Dividend Yield | 3.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
